Aurora Cannabis (TSX:ACB) Stock Is Flying! Should You Buy it?

One of the world’s most popular cannabis companies has seen incredible growth over the past couple days. Should you add it to your portfolio?

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

Cannabis stocks have been on quite a roller-coaster ride since 2015. Taking Aurora Cannabis (TSX:ACB)(NYSE:ACB) as a case study, it saw more than a 3,300% gain from the 2015 Canadian Federal Election to its highest points in 2018. Even in 2018, Aurora Cannabis stock saw two dips of 50% or greater before recovering and commencing the amazing fall we have seen in recent years. Over the past week, this stock has been absolutely flying. Should investors add it to their portfolio?

Why are cannabis stocks soaring?

In 2018, the use of recreational marijuana became legal in Canada. This was one of the major talking points of the Liberal Party’s platform during the 2015 Federal Election. In anticipation of its legalization, companies that operated in this space saw incredible runs in 2017. It’s a perfect example of “buy the rumour and sell the news.”

As mentioned earlier, Aurora Cannabis saw a maximum gain of over 3,300% from election night to its highest point in October 2018. Meanwhile, other companies like Canopy Growth saw a max gain of nearly 3,200%. Aphria had a lesser, but still very impressive gain of 2,400%.

One of the points in the platform of the Biden-Harris team in this year’s United States presidential election is the decriminalization of adult-use marijuana and the legalization of medicinal uses federally. Currently, 15 states have fully legalized marijuana, whereas another 28 have either legalized the use of medicinal marijuana or have approved its decriminalization. However, it remains illegal at the federal level.

Now, with Joe Biden at the cusp of a presidential victory, cannabis stocks are flying. As of this writing, Aurora Cannabis and Aphria stock have increased 52% and 20% over the past five days, respectively, and Canopy Growth has gained 48% over the past month. If Joe Biden is able to grab the win, there is a good chance that cannabis companies may absolutely explode.

Should investors buy cannabis stocks now?

A famous Mark Twain quote comes to mind in this situation: “History doesn’t repeat itself, but it often rhymes.” We have seen what happens when marijuana gets recognized at the federal level. Cannabis stocks went on incredible runs up until it was legalized, and the stocks proceeded to fall to all-time low after all-time low.

I would be very careful in purchasing shares of these companies right now. The market has seen a lot of activity from short-term traders affecting stocks this year. If an investor gives into the FOMO (fear of missing out), there is a chance they can get burned badly.

I am also not a fan of Aurora Cannabis. I think the company is run rather poorly. In May this year, Aurora Cannabis consolidated its shares through a 12:1 reverse stock split. This indicates that the company’s stock has been going through incredibly rough times.

In addition, in early October, it was reported that Aurora Cannabis handed out millions of dollars in compensation and salary increases to executives while laying off more than 1,000 employees. The company also reported billions in losses around this time.

Foolish takeaway

There is no doubt that cannabis stocks have been flying as of late. A lot of this buying pressure may be a result of Joe Biden’s probable presidential victory. However, I think it is extremely dangerous to chase stocks as they go on blistering runs. I am not a fan of Aurora Cannabis because of the company’s history and management. If investors are truly interested in this industry, I would recommend patience and heightened prudence.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jed Lloren has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »